Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclosporin A--usefulness, risks and mechanism of action.

× No keyword cloud information.

39 in total

1. Analysis of isolated and combined effects of calcium ionophore and phorbol ester on T lymphocyte activation.

Authors: A F Nóbrega; M S Maldonado; G A Dos Reis
Journal: Clin Exp Immunol Date: 1986-09 Impact factor: 4.330

2. Immunotoxicity of immunotherapeutic agents.

Authors: A G Johnson; J Regal
Journal: Springer Semin Immunopathol Date: 1985

Review 3. Gingival enlargement induced by drugs.

Authors: L Brunet; J Miranda; M Farré; L Berini; C Mendieta
Journal: Drug Saf Date: 1996-09 Impact factor: 5.606

4. Side effects of low-dose cyclosporin A in the treatment of multiple sclerosis.

Authors: P Bramanti; M Di Leo; R M Ricci; G P De Luca; P Di Bella; C Rifici
Journal: Ital J Neurol Sci Date: 1990-02

5. Differential effect of cyclosporin A on activation signaling in human T cell lines.

Authors: B Manger; K J Hardy; A Weiss; J D Stobo
Journal: J Clin Invest Date: 1986-05 Impact factor: 14.808

6. Interferon-induced expression of class II major histocompatibility antigens in the major histocompatibility complex (MHC) class II deficiency syndrome.

Authors: S Plaeger-Marshall; A Haas; L T Clement; J V Giorgi; I S Chen; S G Quan; R A Gatti; E R Stiehm
Journal: J Clin Immunol Date: 1988-07 Impact factor: 8.317

Cyclosporin A--usefulness, risks and mechanism of action.

1. Analysis of isolated and combined effects of calcium ionophore and phorbol ester on T lymphocyte activation.

2. Immunotoxicity of immunotherapeutic agents.

Review 3. Gingival enlargement induced by drugs.

4. Side effects of low-dose cyclosporin A in the treatment of multiple sclerosis.

5. Differential effect of cyclosporin A on activation signaling in human T cell lines.

6. Interferon-induced expression of class II major histocompatibility antigens in the major histocompatibility complex (MHC) class II deficiency syndrome.

Review 7. Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

8. Allogeneic lymphocyte cytotoxicity in rats: the effects of various pharmacological agents.

9. Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeks.

10. Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse.